Senescent cells in systemic aging: SASP heterogeneity, immune escape, and endocrine modulation
Louay Abo Qoura1,2,3, Alexey V Churov4, O N Maltseva5
1Russian Gerontology Clinical Research Centre, Pirogov Russian National Research Medical University, 129226, Moscow, Russia. louay.ko@gmail.com.
Biogerontology
|May 11, 2026
Summary
Cellular senescence drives aging-related inflammation via the senescence-associated secretory phenotype (SASP). Senescent cells persist, promoting inflammaging through diverse signaling pathways and immune evasion.
Area of Science:
- Gerontology
- Immunology
- Cell Biology
Background:
- Aging leads to reduced resilience and increased disease risk.
- Cellular senescence, marked by the senescence-associated secretory phenotype (SASP), is a key aging hallmark driving inflammation.
- Senescent cells accumulate with age, releasing inflammatory factors that alter tissue environments.
Purpose of the Study:
- To review the current understanding of tissue-specific SASP programs.
- To highlight mechanisms amplifying local senescence into systemic inflammation.
- To discuss the role of nucleic acid-sensing pathways and immune evasion in senescent cell persistence.
Main Methods:
- Literature review synthesizing current research on cellular senescence and aging.
- Analysis of tissue-specific SASP variations across immune, vascular, metabolic, hepatic, and neural systems.
- Examination of molecular mechanisms driving SASP and its systemic effects.
Main Results:
- SASP composition is heterogeneous, varying by cell type, metabolism, and stressor.
- Nucleic acid-sensing pathways (e.g., cGAS-STING, RIG-I) sustain senescence-associated inflammation.
- Senescent cells employ immune-evasion tactics, contributing to their persistence in aging tissues.
Conclusions:
- Senescent cell accumulation is a critical link between molecular damage and inflammaging.
- Mechanisms like endocrine signaling, extracellular vesicles, and sex-dependent modulation amplify senescence-driven inflammation.
- Targeting cellular senescence and SASP may offer therapeutic strategies for age-related diseases.
Related Concept Videos
Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Cellular Adaptation I: Introduction and Atrophy
Cells can adapt to environmental changes to maintain function and avoid injury, a process called cellular adaptation. Adapted cells exist in a reversible intermediate state with changes in size, number, phenotype, metabolism, or function. These responses help cells meet altered physiological or pathological demands; for example, enlargement of breast and uterine tissues during pregnancy. Early adaptations may enhance function, but persistent stress eventually causes tissue damage.Types of...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...


